D-0205-2017 Class III Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

FDA drug recall D-0205-2017 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Jun 13, 2016 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date: incorrect expiration date of 02/0218 is printed on the container label instead of the correct expiration date of 02/2018. The recall status is terminated (terminated Jul 12, 2017). Affected quantity: 1512 bottles.

Recall Details

Product Type
Drugs
Report Date
Dec 21, 2016
Initiation Date
Jun 13, 2016
Termination Date
Jul 12, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1512 bottles

Product Description

Methylprednisolone Tablets, USP, 16 mg, 50-count bottles, Rx only, Manufactured by Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-003-14.

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date: incorrect expiration date of 02/0218 is printed on the container label instead of the correct expiration date of 02/2018.

Distribution Pattern

Nationwide and Puerto Rico.

Code Information

Lot #: 16P0176, Exp 02/2018 but labeled incorrectly as 02/0218.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0205-2017
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.